MAPK-IN-4
MAPK-IN-4 (Compound c1) is an orally active anti-inflammatory agent that inhibits the expression and release of pro-inflammatory cytokines IL-6 and TNF-α induced by LPS. It interacts with IRAK4 to exert its anti-inflammatory effects by inhibiting the MAPK pathway.
Product Specifications
Field of Research
Immunology & Inflammation, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
3525-biotin-002mg 0.02 mg
SARS-CoV-2 (COVID-19) Spike Antibody (biotin)
Sign In for Pricing
View Details 
IRBAMLRPS6KB1AP999120UL 1 Each
Rabbit Anti RPS6KB1 Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 50% glycerol, pH7.3) (Immunofluorescence)
Sign In for Pricing
View Details K3611406 1.0 µg DNA
Acnat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details